Related Posts
The world’s highest-grade ionic clay
29 May 2023 - Dr Andrew Tunks, Executive Chairman of Meteoric Resources (ASX:MEI), provides an update on the company's progress, discussing its transition from gold to rare earths, the advantages of ionic clay over hard rock deposits, and promising early results.
Read More
WT Financial Group (ASX:WTL) FY2023 full-year indicative results
08 Aug 2023 - WT Financial Group Limited (ASX:WTL) Managing Director Keith Cullen discusses drivers of profitability, the effect of lower adviser numbers in the industry and opportunities moving forward.
Read More
Next Science (ASX:NXS) – breakthrough antimicrobial technologies
27 May 2021 - Next Science Limited (ASX:NXS) Founder and Chief Technology Officer Dr Matthew Myntti talks about the problem of biofilms, Next Science's antimicrobial treatments and the company's recent FDA approval.
Read More
45 years in financial services: A conversation with Bernie Fernandes
06 Sep 2024 - Bernie Fernandes, State Manager (WA & SA) of Sequoia Financial Group (ASX:SEQ), talks with CEO and Managing Director Garry Crole. Bernie shares insights for advisors from his long career.
Read More
Beyond the top 50: The case for small and mid caps
03 June 2025 - How Mirrabooka manages ris, navigates volatility and uncovers value.
Read More
Magnis’s iM3NY lithium-ion battery plant begins commercial production
12 Aug 2022 - Magnis Energy Technologies Limited (ASX:MNS) Executive Chairman Frank Poullas discusses the pathway to revenues and increasing capacity as the company's battery gigafactory commences production.
Read More
“Mafic intrusive units are super rare”: Terrain Minerals (ASX:TMX) talks nickel, gallium and gold
09 Sep 2024 - Terrain Minerals Limited (ASX:TMX) Executive Director Justin Virgin discusses the company's promising projects in Western Australia.
Read More
ResApp Health (ASX:RAP) – managing respiratory disease and sleep apnoea
07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management of respiratory conditions and sleep apnoea, discussing its launch of the ResAppDx smartphone-based acute respiratory diagnostic test.
Read More
AD1 Holdings (ASX:AD1) FY21 results and outlook
23 Sep 2021 - AD1 Holdings Limited (ASX:AD1) CEO and Managing Director Brendan Kavenagh provides an update on the company's suite of software as a service businesses, FY21 results and outlook.
Read More
Radiopharm Theranostics (ASX:RAD) to start prostate cancer trial
07 Jul 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's portfolio of therapies.
Read More